Suppr超能文献

[实验性肝硬化发展过程中大鼠肝脏组胺受体的变化]

[Changes of histamine receptors in the liver of the rat during the development of experimental cirrhosis].

作者信息

Peng J, Leng X, Wei Y

机构信息

People's Hospital, Beijing Medical University.

出版信息

Zhonghua Wai Ke Za Zhi. 1996 Feb;34(2):113-6.

PMID:9388338
Abstract

It remains unknown whether changes of histamine H1 and H2 recepters in the liver occur during the development of cirrhosis. 48 male Wistar rats were divided, equally and randomly, into experiment and control groups, and the rats in the experiment group were induced by CCl4 to form experimental cirrhosis models. Then, at different stages during the development of experimental cirrhosis, the maximal binding capacity (Bmax), dissociation constants (Kd), and binding ability (BA = Bmax/Kd) of histamine H1 and H2 receptors in the livers of the two groups were analysed by radioligand binding assay. At early stage of the development of experimental cirrhosis, the Bmax of H2 receptor in the rat liver was not statistically different from that of normal control; at middle and advanced stages of the course, the Bmax of H2 recepter were significantly lower than normal. The Bmax of H1 receptor was obviously lower than normal at each stage. At middle stage, the Kd of H1 receptor was significantly higher than normal, whereas the Kd of H1 receptor at the other two stages and the Kd of H2 receptor at each stage were not remarkably different from those of the controls. At each stage of the development of experimental cirrhosis, the BA of H1 and H2 receptor was all significantly lower than that of the normal controls. It was concluded that the "down-regulation" of the receptors may be an important factor for the reduction of Bmax and BA of the two histamine receptors, and these changes of the receptors may possibly led to metabolic disorder of carbohydrates and phospholipid in the liver and lower the liver's ability to inactivate histamine.

摘要

在肝硬化发展过程中肝脏中组胺H1和H2受体是否发生变化仍不清楚。将48只雄性Wistar大鼠平均随机分为实验组和对照组,实验组大鼠用四氯化碳诱导形成实验性肝硬化模型。然后,在实验性肝硬化发展的不同阶段,采用放射性配体结合分析法分析两组大鼠肝脏中组胺H1和H2受体的最大结合容量(Bmax)、解离常数(Kd)和结合能力(BA = Bmax/Kd)。在实验性肝硬化发展的早期,大鼠肝脏中H2受体的Bmax与正常对照组相比无统计学差异;在病程的中晚期,H2受体的Bmax明显低于正常水平。H1受体的Bmax在各个阶段均明显低于正常水平。在中期,H1受体的Kd明显高于正常水平,而在其他两个阶段H1受体的Kd以及在各个阶段H2受体的Kd与对照组相比无明显差异。在实验性肝硬化发展的各个阶段,H1和H2受体的BA均明显低于正常对照组。结论是,受体的“下调”可能是两种组胺受体Bmax和BA降低的重要因素,这些受体的变化可能导致肝脏中碳水化合物和磷脂的代谢紊乱,并降低肝脏灭活组胺的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验